Q4 TCE performance. TCE income – Shipping Q4 2025 concluded at US$50,300 per available day, above our guidance of US$47,000 ...
Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552.HK) announced today that its global first-in-class glucokinase activator (GKA) dorzagliatin (Trade name: MYHOMSIS®, 華領片®) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results